Preparation of Diclofenac Diethylamine Nanoemulsions by Ultrasonication-Stability and Process Parameter Evaluation
under Various Conditions
Praveen Kumar Gupta1*, J.K. Pandit, P.J. Narain, R.N. Gupta
and Sanjiv Kumar Gupta
1Agra Public Institute of
Technology and Computer Education, Agra
Department
of Pharmaceutics, IIT-B.H.U., Varanasi.
Department of Pharmaceutical
Sciences, B.I.T. Mesra
ABSTRACT:
In
this study, oil-in-water nanoemulsions of Diclofenac Diethylamine were produced by Ultrasonication.
The influence of emulsifying conditions including emulsifier type and concentration,
homogenization pressure, temperature, cycle, on time, off time and total time
on the properties and stability of the nanoemulsions
were investigated using a Zetasizer. The mean
diameters (z-average) of the dispersed particles containing Diclofenac Diethylamine ranged from 50.57 to 154.9 nm and the polydispersity index ranged from 0.318 to 0.719 and the
zeta potential ranged from19.2 to35.3. The nanoemulsions
produced with Tween-80 had the smallest particle sizes and narrowest size
distribution. The particle sizes decreased with increases in homogenization
pressure and cycle, and also with temperature up to 40ºC. The physical
stability of the nanoemulsions increased with the
elevation of temperature up to 40º C, with pressure up to 200 MPa and homogenization cycle (up to three cycles).
KEYWORDS: Nanoemulsion; Diclofenac Diethylamine, Ultrasonication; Particle size; Zetasizer;
INTRODUCTION:
In
the last two decades, nanotechnology is rapidly emerging as one of the most
promising and attractive research fields. The technology offers the potential
to significantly improve the solubility and bioavailability of many functional
ingredients including Diclofenac Diethylamine and
numerous other compounds. Hitherto, however, researches into the application of
this technology in the industry have been limited and there are only a few
publications that explored the use of this technology for preparing nanoemulsions by ultrasonication.1
Ultrasonic
emulsification is believed to occur through two mechanisms. Firstly, the
application of an acoustic field produces interfacial waves which become
unstable, eventually resulting in the eruption of the oil phase into the water
medium in the form of droplets 2 Secondly, the application of low
frequency ultrasound causes acoustic cavitations, that is, the formation and
subsequent collapse of micro bubbles by the pressure fluctuations of a simple
sound wave. Each bubble collapse (an implosion on a microscopic scale) event
causes extreme levels of highly localized turbulence. The turbulent
micro-implosions act as a very effective method of breaking up primary droplets
of dispersed oil into droplets of sub-micron size3.
Studies to date
comparing ultrasonic emulsification with rotor–stator dispersing have found
ultrasound to be competitive or even superior in terms of droplet size and
energy efficiency 4 It may also
be more practicable with respect to production cost, equipment contamination
and aseptic processing than a microfluidisation
approach.5 comparing mechanical agitation to ultrasound at low
frequency,6 found that
for a given desired diameter, the surfactant amount required was reduced,
energy consumption (through heat loss) was lower and the ultrasonic emulsions
were less polydisperse and more stable.
Diclofenac
is a well-established Non steroidal anti-inflammatory agent, widely used in
musculoskeletal disorders, arthritis, toothache, dysmenorrhea, symptomatic
relief of pain and inflammation7. Diethylamine
salt of diclofenac is reportedly used for topical
application8Diclofenac Diethylamine
possess the ideal characteristics for the preparation of novel drug delivery
system, such as short biological half-life (2-3 hr), smaller dose (25-50mg) one
of the approaches that can be used to improve the solubility and bioavailability
of Diclofenac Diethylamine is to incorporate them in
the fine particles of oil-in water (O/W) nanoemulsions.
In
this article, Diclofenac Diethylamine nanoemulsion by ultrasonication were prepared and investigated the
influence of phase ratio of emulsifier and their concentration, homogenization
pressure, homogenization cycle,
temperature ,on time , off time and total time exposure on particle size
parameters, polydispersity and zeta potential of the nanoemulsions was systematically examined using a dynamic
light scattering (DLS) technique.
MATERIALS AND
METHODS:
Materials:
Diclofenac Diethylamine (Pulverised) was a
gift sample from Pee-Medica(Agra, India). Isopropyl myristate (IPM), Tween-80 and Tween-20 were purchased from
E-Merck (Mumbai, India). Diethylene glycol monoethyl ether
(Transcutol ), were purchased from CDH. All other chemicals used in the
study were of analytical reagent grade.
Preparation of
Diclofenac Diethylamine nanoemulsions:
Oil-in-water
(O/W) nanoemulsions were prepared using Isopropyl Myristate oil, Tween-80 and Tween-20 as the emulsifier, Transcutol as cosurfactant,
Diclofenac Diethylamine as the drug, as dispersed
phase and Milli-Q water as the continuous phase. The
emulsifier was used Tween-20 and Tween-80 the concentration (in the final
emulsion) were 5% and 10% at a fixed homogenization temperature, stage pressure
and cycle (40ºC, 150 MPa, and three cycles),
respectively. The emulsions were sampled and their particle size, size
distribution and emulsion stability were measured.
Using
the above procedure, several batches were prepared by varying the emulsifier
and their concentration, and homogenization pressure, temperature and cycle to
study their effects on the characteristics of the nanoemulsions.
Ultrasonication Process:
Ultrasonication process performed under
optimized operating conditions of power intensity, homogenization cycle,
temperature, total time and reaction time (On time and off time). 100ml
dilution formulation mixes were taken into reaction vessel the horn probe of ultrasonicator was directly immersed into the reaction
vessel at a depth of about 1cm for every running.
Figure 1: Probe Sonicator
Used In Laboratory Scale for Preparation of Nanoemulsion
Analysis of particle size and
distribution:
The
average particle size and size distribution of the nanoemulsions
were determined by dynamic light scattering using a Zetasizer
Nano-ZS (Malvern Instruments, Worcestershire, UK).
The measurement was carried out at a fixed angle of 90º with the samples
diluted approximately 100 times with Milli-Q water.
The particle size of the emulsions was described by the cumulants
mean (z-average) diameter and the size distribution by the polydispersity
index (PdI).
Evaluation of emulsion stability:
The
stability of the nanoemulsions was evaluated by Zeta
potential using Zetasizer.
Statistical analysis:
The
whole experiment was conducted in duplicate and all analyses were done at least
in triplicate. The data were analyzed by one way analysis of variance (ANOVA)
using the SPSS 12.0 package. Significant differences of means were determined
by the Duncan’s multiple range tests.
Table 1: Praticle size, Polydispersity
index and Zeta Potential of Diclofenac Diethylamine nanoemulsions
prepared with different emulsifiers concentration
(mean
± SD, n=3)a
Emulsifiers |
Property |
Concentration
of emulsifiers |
|
5% |
10% |
||
Tween-20 |
D(nm)b PdIc Zeta potential (mV) |
152.6±4.28 0.537±0.050 -24.6±0.6 |
68.97±1.12 0.363±0.033 -27.2±0.4 |
Tween-80 |
D(nm) PdI Zeta potential (mV) |
115.1±1.82 0.337±0.026 -23.9±0.4 |
57.50±1.62 0.318±0.024 -35.3±0.3 |
A–I For
the PdI values, data followed significantly different
(P < 0.05).
a. The emulsions were prepared at the homogenization temperature,
pressure and cycle of 40ºC, 150 MPa and 3 cycles,
respectively.
b. D (nm), cumulant mean (z-average) diameter
of the nanoemulsion particles.
c. PdI, polydispersity
index.
Figure 2: Particle Size and Zeta Potential of Diclofenac Diethylamine nanoemulsion
different emulsifier and concentration
(i-a) Particle Size distribution in the Diclofenac Diethylamine
nanoemulsion Prepared with Tween-20 at a
Concentration 5% w/w and a 150 MPa and 40ºC
(i-b) Zeta Potential of
Diclofenac Diethylamine nanoemulsion
Prepared with Tween-20 at a Concentration 5% w/w
(ii-a) Particle Size distribution
in the Diclofenac Diethylamine
nanoemulsion Prepared with Tween-80 at a
Concentration 5% w/w and a 150 MPa and 40ºC
(iii-a) Particle Size
distribution in the Diclofenac Diethylamine
nanoemulsion Prepared with Tween-20 at a
Concentration 10% w/w and a 150 MPa and 40ºC
(iv-a)Particle Size
distribution in the Diclofenac Diethylamine
nanoemulsion Prepared with Tween-80 at a
Concentration 10% w/w and a 150 MPa and 40ºC
(ii-b) Zeta Potential of Diclofenac Diethylamine
nanoemulsion Prepared with
Tween-80 at a Concentration 5% w/w
(iii-b) Zeta Potential of Diclofenac Diethylamine
nanoemulsion Prepared with
Tween-20 at a Concentration 10% w/w
(iv-b) Zeta Potential of Diclofenac Diethylamine
nanoemulsion Prepared with
Tween-80 at a Concentration 10% w/w
Table 2: Praticle size, Polydispersity
index and Zeta Potential of Diclofenac Diethylamine nanoemulsions
prepared at different homogenization Cycles
(mean ± SD, n=3)a
Homogenization
Cycles |
I |
II |
III |
D (nm) |
154.9 ± 1.6 |
112.4 ± 1.3 |
57.88 ± 0.9 |
PdI |
0.532 ± 0.005 |
0.447 ± 0.003 |
0.386 ± 0.002 |
Zeta potential (mV) |
-23.3 ± 0.7 |
-28.4 ± 0.4 |
-34.8 ± 0.7 |
A–I
For the PdI values, data followed
significantly different (P < 0.05).
Figure 3: Particle Size and Zeta Potential of
Diclofenac Diethylamine nanoemulsions
prepared at different homogenization cycles
(i-a) Particle Size distribution
in the Diclofenac
Diethylamine nanoemulsion Ist Homogenization
Cycle
(i-b) Zeta Potential of Diclofenac Diethylamine
nanoemulsion in
Ist Homogenization Cycle
(ii-a) Particle Size distribution in the Diclofenac Diethylamine nanoemulsion
IInd Homogenization Cycle
(iii-b) Zeta Potential of Diclofenac Diethylamine
nanoemulsion in IInd Homogenization Cycle
(iv-a) Particle Size distribution
in the Diclofenac
Diethylamine nanoemulsion IIIrd Homogenization Cycles
(iv-b)Zeta Potential of Diclofenac Diethylamine
nanoemulsion in IIIrd Homogenization Cycle
Table 3: Praticle size, Polydispersity
index and Zeta Potential of Diclofenac Diethylamine nanoemulsions prepared at different homogenization
temperatures (mean ± SD, n=3)a
Temperature
(ºC) |
20 |
40 |
60 |
D (nm) |
64.54±1.2 |
50.57±1.1 |
96.9±1.4 |
PdI |
0.471±0.009 |
0.456±0.004 |
0.719±0.048 |
Zeta potential (mV) |
-25.6±0.8 |
-33.9±0.7 |
-31.6±0.9 |
A–I
For the PdI values, data followed
significantly different (P < 0.05).
Figure 4: Particle Size and Zeta
Potential of Diclofenac Diethylamine nanoemulsions prepared at different homogenization Temperature
(i-a) Particle Size distribution in the Diclofenac Diethylamine nanoemulsion
at 200C Homogenization Temperature
(i-b) Zeta Potential of Diclofenac Diethylamine
nanoemulsion
at 200C Homogenization Temperature
(ii-a) Particle Size
distribution in the Diclofenac Diethylamine
nanoemulsion at 400C Homogenization
Temperature
(ii-b) Zeta Potential of Diclofenac Diethylamine
nanoemulsion
at 400C Homogenization Temperature
(iii-a) Particle Size
distribution in the Diclofenac Diethylamine
nanoemulsion at 600C Homogenization
Temperature
(iii-b)Zeta Potential of Diclofenac Diethylamine
nanoemulsion
at 600C Homogenization Temperature
Figure 5: Particle Size and Zeta
Potential of Diclofenac Diethylamine nanoemulsions prepared at different homogenization pressure
(i-a)Particle Size
distribution in the Diclofenac Diethylamine
nanoemulsion at 50 MPa
Homogenization Pressure
(i-b)Zeta Potential of Diclofenac Diethylamine
nanoemulsion
at
50
MPa
Homogenization Pressure
(ii-a)Particle Size
distribution in the Diclofenac Diethylamine
nanoemulsion at 100 MPa
Homogenization Pressure
(iii-a)Particle Size
distribution in the Diclofenac Diethylamine
nanoemulsion at 150 MPa
Homogenization Pressure
(iv-a)Particle Size
distribution in the Diclofenac Diethylamine
nanoemulsion at 200 MPa
Homogenization Pressure
Table 4: Praticle size, Polydispersity
index and Zeta Potential of Diclofenac Diethylamine nanoemulsions prepared at different homogenization
pressures (mean ± SD, n=3)a
Pressures
(MPa) |
50 |
100 |
150 |
200 |
D (nm) |
150.9 ± 0.9 |
92.2 ± 0.7 |
59.64 ± 0.5 |
68.08 ± 0.6 |
PdI |
0.511 ± 0.024 |
0.622 ± 0.036 |
0.324 ± 0.014 |
0.351 ± 0.019 |
Zeta potential (mV) |
-19.2 ± 0.3 |
-25.8 ± 0.4 |
-32.5 ± 0.5 |
-34 ± 0.8 |
A–I
For the PdI values, data followed
significantly different (P < 0.05).
(ii-b)Zeta Potential of Diclofenac Diethylamine
nanoemulsion at 100 MPa Homogenization Pressure
(iii-b) Zeta Potential of Diclofenac Diethylamine
nanoemulsion at 150 MPa Homogenization Pressure
(iv-b) Zeta Potential of Diclofenac Diethylamine
nanoemulsionat 200 MPa H omogenization Pressure
RESULTS AND DISCUSSION:
Ultrasonication is one of the most frequently used techniques for preparing emulsions.
The Diclofenac Diethylamine nanoemulsions
prepared in this study were typical oil-in-water (O/W) emulsions. It is well
known that emulsifying parameters such as the type and concentration of
emulsifiers, homogenization temperature, pressure and cycle can affect the
physicochemical properties and stability of the emulsions. Therefore, this
study was conducted to investigate the effect of these parameters on the
properties of the Diclofenac Diethylamine nanoemulsions with the aim of finding the optimal
conditions.
Effect of the emulsifiers and their
concentration change on the Praticle size and Polydispersity index:
Particle
size parameters of Diclofenac Diethylamine nanoemulsions prepared with different emulsifiers Tween-80
and Tween-20 at various concentration 5% and 10%. The cumulates mean diameters
(z-average) of the nanoemulsion particles of Tween-80 at 5% is 115.1 and at
10% is 57.5, with the polydispersity index (PdI) 0.337 and 0.318 respectively, while Tween-20 at 5%
particle size is 152.6 and at 10% 68.97 with polydipersity index 0.537 and 0.363 respectively.
These
results therefore proved that the nonionic emulsifiers, Tween-80 and Tween-20,
can be used to produce Diclofenac Diethylamine
emulsions with the dispersed droplets in the nanometer range. Of the two
different emulsifiers used, Tween-80 produced nanoemulsions
with the smallest particle size at 10% concentrations studied. These observations can probably be explained
by the higher solubility of the drug in the emulsifier, emulsifiers with
greater solubility could wrap and stabilize the particles in an O/W emulsion
more efficiently, thus resulting in smaller particles.
As
expected, increasing the emulsifier concentration from 5% to 10% generally
resulted in a significant (P < 0.05) decrease in the particle size. This is
because smaller particle sizes meant greater surface areas, which would require
more emulsifiers to cover. However, the effect of emulsifier concentration on
the particle size reached a plateau for Tween-80 at 10% as reported. This is
most likely due to that at certain emulsifier concentrations, all the droplets
in the emulsion were fully covered by the emulsifiers and excessive emulsifiers
in the system would not be utilized unless the particle sizes could be reduced
further.
The
PdI value measures the spread of the particle size
distribution and, thus, a small PdI value indicates a
narrow particle size distribution.9 In general, the Diclofenac Diethylamine nanoemulsions all
exhibited a relatively narrow range of size distribution with the PdI values range
0.318-0.537 (0 being the smallest and 1 the largest possible values).
Nanoemulsions
prepared with Tween-80 at 10% had the narrowest of size distribution with PdI 0.318.
Effect of homogenization cycle on the Praticle size and Polydispersity
index:
The
effect of homogenization cycle on the properties of Diclofenac Diethylamine nanoemulsions is as
expected; increasing the homogenization cycle resulted in significant decreases
(P < 0.05) in both the particle size and the range of particle distribution.
However, after passing the emulsion through the ultrasonication
for three times, subsequent passes had no further effect on the particle size.
Furthermore, and in successive homogenization cycles, no further
improvement on the size
distribution was observed .15
Effect of homogenization temperature on
the Praticle size and Polydispersity
index:
Temperature
can influence the particle size of the droplets in emulsions produced by ultrasonication. The influence may come from a number of
ways including its effect on the viscosity, and the interfacial tension
between, the oil and aqueous phases, both of which are temperature dependent 10,
increasing the homogenization temperature from 20 to 40ºC resulted in
significant (P < 0.05) decreases in the particle size. However, increasing
the temperature 60ºC, the size actually increased significantly, at 60ºC and
above it seems that Diclofenac Diethylamine was not
stable.
This
result is not unexpected because Tween-20 (the emulsifier used in this
experiment) has a cloud point of about 76ºC 11 and as the
temperature approached this point, it could begin to lose the ability to
prevent aggregation of emulsion droplets with consequent coalescence of some
droplets12. The effect of homogenization temperature on the size
distribution, however, did not show a consistent pattern, although there were
significant differences in the PdI values of
emulsions prepared at different temperatures. The emulsion produced at the 60ºC
had the highest PdI values, while that prepared at
40ºC had the lowest value.
Effect of homogenization pressure on the Praticle size and Polydispersity
index:
Homogenization
pressure can significantly influence the properties of emulsions as the shear
forces and turbulence, both of which are pressure dependent, produced during
homogenization can affect the particle size and size distribution13,14.
In this study, the effect of homogenization pressure on the properties of the
Diclofenac Diethylamine nanoemulsions
were studied by varying at 50 MPa, 100 MPa, 150 MPa and 200 MPa increasing the homogenization pressure resulted in
significant (P < 0.05) decreases in the particle sizes over the entire
pressure ranges studied, which agreed with the findings 15. However,
at 200 MPa the slight increase in the particle size
distribution.
Effect of emulsifiers and their
concentration, homogenization cycle, temperature and pressure on Zeta potential:
The
stability of the emulsion decreased with a rise in homogenization temperature
over the 60ºC temperature range studied. The emulsion stability increased
initially when the homogenization pressure was raised within the range of 50–200MPa.
Similarly, when the homogenization cycle was increased to up to three cycles,
the emulsion stability increased, but with a further increase in homogenization
cycle, not a constant pattern in emulsion stability was observed. Emulsion
stability is a complex issue and can be influenced by a number of factors
including particle size, viscosity and environmental conditions such as
temperature and shear force. In general, smaller particles have a lesser
tendency to cream but a greater tendency to aggregate because they are more
numerous at a given phase ratio and more susceptible to the influence of
Brownian motion, both of which would lead to greater chance of collision .12
It has been shown that when the particle sizes are smaller than 100 nm
(many particles in the present study fell into this range), creaming would be
greatly reduced and aggregation become a dominant mechanism for emulsion
instability 12. This may partly explain the results of the present
study. As the homogenization temperature increased, the viscosity of the
emulsions would decrease and the Brownian motion become more rapid, both of
which would lead to more frequent particle collisions, with consequent
aggregation and greater emulsion instability. The decreases in the stability of
the nanoemulsions observed at high homogenization
pressures (>200 MPa) and cycles (>3) could also
be partly attributable to the increased particle collision and aggregation.
This is because under these conditions, the collision frequency of the
particles, which is recognized as one of the main contributing factors to
aggregation in emulsions12, would increase.
CONCLUSION:
This
study confirmed that ultrasonication is a relatively
simple and effective technique for producing Diclofenac Diethylamine
oil-in-water nanoemulsions. The particle size and
size distribution of the nanoemulsions were
influenced by the emulsifiers and their concentrations, as well as
homogenization temperature, pressure and cycle. The Diclofenac Diethylamine nanoemulsions had
moderate physical stabilities.
REFERENCES:
1.
Y.Yuan, Y Gao,
J.Zhao, L.Mao Charaeterzation and stability evaluation of β-carotene
nanoemulsions prepared by high pressure
homogenization under various emulsifying conditions food. Res. Int. 2008;
41:61-68.
2.
Li, M. K., and Fogler, H. S. (Acoustic
emulsification. Part 1. The instability of the oil-water interface to form the
initial droplets. Journal of Fluid Mechanics, 1978a); 88(3): 499−511.
3.
Li, M. K., and Fogler, H. S. (Acoustic
emulsification. Part 2. Break-up of the larger primary oil droplets in a water
medium. Journal of Fluid Mechanics, 1978b); 88(3): 513−528.
4.
Ma, Y. F., and Hsu, C. C. Performance of sonication and microfluidizationfor liquid–liquid emulsification.
Pharmaceutical Development and Technology 1999; 4: 233−240.
5.
Abismail, B., Canselier, J., Wilhelm,
A., Delmas, H., and Gourdon,
C. Emulsification by ultrasound: drop size distribution and stability. Ultrasonics Sonocheistry 1999; 6:
75−83.
6.
Tadros, T., Izquierdo, P., Esquena, J., and Solans, C.
Formation and stability of nano-emulsions. Advances
in Colloid and Interface Science 2004; 108–109, 303−318.
7.
John VA. The pharmacokinetics and metabolism of diclofenac
sodium (voltarol TM ) in
animals and man.Rheumatol Rehabil
Suppl 1979; 2: 22-27.
8.
Kriwet K, Mullar Goymunn CC. Binary Diclofenac Diethylamine
water system,micelles
vesicles and lyotropic liquid crystal. Eur J Pharm Biopharm
1993; 39(6): 234-238.
9.
Lemarchand, C., Couvreur, P., Vauthier, C., Costantini, D., and
Gref, R. Study of emulsion stabilization by graft
copolymers using theoptical analyzer Turbiscan. International Journal of Pharmaceutics 2003;
254: 77–82.
10. Floury, J., Desrumaux, A., Axelos, M. A. V.,
and Legrand, J. Effect of high pressure
homogenization on methylcellulose as food emulsifier. Journal of Food
Engineering, 2003; 58: 227–238.
11. Claesson, P. M., Blomberg,
E., and Poptoshev, E. (2004). Surface forces and
emulsion stability. In S. T. Friberg, K. Larsson, and
J. Sjoblom (Eds.), Food emulsions (4th ed.) (pp. 257–298). NY: Marcel Dekker Inc.
12. McClements, D. J. (2005). Food
emulsions: Principles, practices and techniques (2nd ed.).
Boca Raton, FL: CRC Press.
13. Floury, J., Desrumaux, A., and Lardie`res, J.
Effect of high-pressure homogenization on droplet size distributions and
rheological properties of model oil-in-water emulsions. Innovative Food Science
and Emerging Technologies 2000; 1: 127–134.
14. Prajapati, J. P., Jana, A. H., and Upadhyay, K. G. Microfluidization
– A novel approach for homogenization. Indian Dairyman 2004; 56 (3): 39–44.
15. Tan, C. P., and Nakajima, M.
Effect of polyglycerol esters of fatty acids on
physicochemical properties and stability of b-carotene nanodispersions
prepared by emulsification/ evaporation method. Journal of the Science of Food
and Agriculture 2005; 85: 121–126.
Received on 02.09.2011
Accepted
on 11.09.2011
©
A&V Publication all right reserved
Research Journal of Pharmaceutical
Dosage Forms and Technology.
3(6): Nov.- Dec., 2011, 285-293